This inventor holds 3 USPTO granted patents. Top assignees: E.i. Dupont De Nemours and Company, Pharmacopeia Inc.. Active years: 1991-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1999
Title: Alan K Robbins: Innovator in Eukaryotic Cell Technology
Introduction
Alan K Robbins is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic cell lines for protein expression. With a total of 3 patents, Robbins has established himself as a key figure in his area of expertise.
Latest Patents
Robbins' latest patents include innovative methods for producing recombinant eukaryotic cell lines. One of his notable inventions describes a method for producing eukaryotic cells that stably express genes from multiple transfected sources. This method involves transfecting eukaryotic host cells with two different episomes, each containing an EBV origin of replication and a gene encoding a protein of interest. The resulting transfected cells express an EBNA 1 protein and are cultivated under specific conditions to ensure the expression of both genes. Another significant patent discusses recombinant pseudorabies virus and its applications in producing proteins with medical, agricultural, and industrial utilities.
Career Highlights
Throughout his career, Robbins has worked with prominent companies such as E.I. du Pont de Nemours and Company and Pharmacopeia Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative biotechnological solutions.
Collaborations
Robbins has collaborated with esteemed colleagues, including Lynn W Enquist and Mary E Whealy. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Alan K Robbins is a distinguished inventor whose work in eukaryotic cell technology has paved the way for advancements in biotechnology. His innovative patents and collaborations highlight his commitment to scientific progress and the development of useful applications in various fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
